Risk estimation for the primary prevention of cardiovascular disease: considerations for appropriate risk prediction model selection

被引:0
|
作者
van Daalen, Kim Robin [1 ,2 ]
Zhang, Dudan [1 ,2 ]
Kaptoge, Stephen [1 ,2 ]
Paige, Ellie [7 ,8 ,9 ]
Di Angelantonio, Emanuele [1 ,2 ,3 ,4 ,5 ,6 ,10 ]
Pennells, Lisa [1 ,2 ]
机构
[1] Univ Cambridge, British Heart Fdn, Cardiovasc Epidemiol Unit, Dept Publ Hlth & Primary Care, Cambridge CB2 0BB, England
[2] Univ Cambridge, Victor Phillip Dahdaleh Heart & Lung Res Inst, Cambridge, England
[3] Univ Cambridge, British Heart Fdn Ctr Res Excellence, Cambridge, England
[4] Univ Cambridge, Natl Inst Hlth & Care Res, Blood & Transplant Res Unit Donor Hlth & Behav, Cambridge, England
[5] Wellcome Genome Campus, Hlth Data Res UK Cambridge, Cambridge, England
[6] Univ Cambridge, Cambridge, England
[7] QIMR Berghofer Med Res Inst, Populat Hlth Program, Brisbane, QLD, Australia
[8] Univ Queensland, Sch Publ Hlth, Brisbane, QLD, Australia
[9] Australian Natl Univ, Epidemiol & Populat Hlth, Canberra, ACT, Australia
[10] Human Technopole, Hlth Data Sci Ctr, Milan, Italy
来源
LANCET GLOBAL HEALTH | 2024年 / 12卷 / 08期
基金
英国工程与自然科学研究理事会; 英国惠康基金; 英国经济与社会研究理事会; 英国医学研究理事会;
关键词
CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; PRIMARY-CARE; FOLLOW-UP; ASSESSMENT TOOL; GLOBAL BURDEN; 10-YEAR RISK; VALIDATION; SCORE; POPULATION;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Cardiovascular diseases remain the number one cause of death globally. Cardiovascular disease risk scores are an integral tool in primary prevention, being used to identify individuals at the highest risk and guide the assignment of preventive interventions. Available risk scores differ substantially in terms of the population sample data sources used for their derivation and, consequently, in the absolute risks they assign to individuals. Differences in cardiovascular disease epidemiology between the populations contributing to the development of risk scores, and the target populations in which they are applied, can result in overestimation or underestimation of cardiovascular disease risks for individuals, and poorly informed clinical decisions. Given the wide plethora of cardiovascular disease risk scores available, identification of an appropriate risk score for a target population can be challenging. This Review provides an up-to-date overview of guideline-recommended cardiovascular disease risk scores from global, regional, and national contexts, evaluates their comparative characteristics and qualities, and provides guidance on selection of an appropriate risk score.
引用
收藏
页码:e1343 / e1358
页数:16
相关论文
共 50 条
  • [1] Prediction of Cardiovascular Risk to Guide Primary Prevention
    Curfman, Gregory D.
    [J]. JAMA INTERNAL MEDICINE, 2018, 178 (09) : 1240 - 1241
  • [2] Risk functions and the primary prevention of cardiovascular disease
    Grau, Maria
    Marrugat, Jaume
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2008, 61 (04): : 404 - 416
  • [3] Risk scoring for the primary prevention of cardiovascular disease
    Karmali, Kunal N.
    Persell, Stephen D.
    Perel, Pablo
    Lloyd-Jones, Donald M.
    Berendsen, Mark A.
    Huffman, Mark D.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (03):
  • [4] Estimation of Lifetime Risk of Cardiovascular Disease (IBERLIFERISK): A New Tool for Cardiovascular Disease Prevention in Primary Care
    Brotons, Carlos
    Moral, Irene
    Fernandez, Diana
    Puig, Mireia
    Calvo Bonacho, Eva
    Martinez Munoz, Paloma
    Catalina Romero, Carlos
    Quevedo Aguado, Luis Javier
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2019, 72 (07): : 562 - 568
  • [5] Genetic Risk Prediction for Primary and Secondary Prevention of Atherosclerotic Cardiovascular Disease: an Update
    Labos, Christopher
    Thanassoulis, George
    [J]. CURRENT CARDIOLOGY REPORTS, 2018, 20 (05)
  • [6] Genetic Risk Prediction for Primary and Secondary Prevention of Atherosclerotic Cardiovascular Disease: an Update
    Christopher Labos
    George Thanassoulis
    [J]. Current Cardiology Reports, 2018, 20
  • [7] Assessment of Atherosclerotic Cardiovascular Disease Risk in Primary Prevention
    Rikhi, Rishi
    Shapiro, Michael D.
    [J]. JOURNAL OF CARDIOPULMONARY REHABILITATION AND PREVENTION, 2022, 42 (06) : 397 - 403
  • [8] Statins for primary prevention: problems with cardiovascular-risk estimation?
    Željko Reiner
    [J]. Nature Reviews Cardiology, 2013, 10 : 547 - 547
  • [9] Aspirin for the Primary Prevention of Cardiovascular Events: Considerations Regarding the Risk/Benefit
    Franklin, Barry A.
    [J]. PHYSICIAN AND SPORTSMEDICINE, 2010, 38 (01): : 158 - 161
  • [10] Statins for the primary prevention of cardiovascular disease in low cardiovascular risk Koreans
    Kim, JuYoung
    Ryou, Insun
    Park, Hwa Yeon
    Oh, Sohee
    Kim, JeongHyun
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 399 - 399